Characterization of Interleukin-4-Stimulated Nasal Polyp Fibroblasts

American Journal of Respiratory Cell and Molecular Biology

Volumn 30, Issue 2, 2004, Pages 212-219

  Steinke, John W ^a   Crouse, Charles D ^a   Bradley, Dewayne ^a   Hise, Kathleen ^a   Lynch, Kevin ^a   Kountakis, Stilianos E ^a   Borish, Larry ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; EOTAXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 11; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 4; PEPTIDOLEUKOTRIENE; RANTES; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; NOSE POLYP; PROTEIN EXPRESSION; PROTEIN INDUCTION; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION; UPREGULATION;

CELL LINE; CHEMOKINES; CYTOKINES; FIBROBLASTS; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; LEUKOTRIENES; MEMBRANE PROTEINS; NASAL POLYPS; RECEPTORS, INTERLEUKIN-4; RECEPTORS, LEUKOTRIENE; RNA, MESSENGER; SINUSITIS;

EID: 0742324996     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2003-0071OC     Document Type: Article

References (44)

1. Hamilos, D. L., D. Y. Leung, R. Wood, D. K. Bean, Y. L. Song, E. Schotman, and Q. Hamid. 1996. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-α. Am. J. Respir. Cell Mol. Biol. 15:443-450.
2. Borish, L. 2002. Sinusitis and asthma: entering the realm of scientific study. J. Allergy Clin. Immunol. 109:606-608.
3. Ferguson, B. J. 2000. Eosinophilic mucin rhinosinusitis a distinct clinicopathological entity. Laryngoscope 110:799-813.
4. Hamilos, D. L. 2001. Noninfectious sinusitis. ACI International 13:27-32.
5. Bachert, C., M. Wagenmann, U. Hauser, and C. Rudack. 1997. IL-5 synthesis is upregulated in human nasal polyp tissue. J. Allergy Clin. Immunol. 99:837-842.
6. Minshall, E. M., L. Cameron, F. Lavigne, D. Y. M. Leung, D. Hamilos, A. Garcia-Zepada, M. Rothenberg, A. D. Luster, and Q. Hamid. 1997. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am. J. Respir. Cell Mol. Biol. 17:683-690.
7. Hamilos, D. L., D. Y. M. Leung, D. P. Huston, A. Kamil, R. Wood, and Q. Hamid. 1998. GM-CSF, IL-5, and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis. Clin. Exp. Allergy 28:1145-1152.
8. Steinke, J. W., D. Bradley, P. Arango, C. D. Crouse, H. Frierson, S. E. Kountakis, M. Kraft, and L. Borish. 2003. Cytseinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: Importance to eosinophilia and asthma. J. Allergy Clin. Immunol. 111:342-349.
9. Virchow, J. C., Jr., S. Faehndrich, C. Nassenstein, S. Bock, H. Matthys, and W. Luttmann. 2001. Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells. Clin. Exp. Allergy 31:836-844.
10. Ohshima, N., H. Nagase, T. Koshino, M. Miyamasu, M. Yamaguchi, K. Hirai, K. Yamamoto, N. Fujisawa, K. Kishikawa, and Y. Morita. 2002. A functional study on CysLT1 receptors in human eosinophils. Int. Arch. Allergy Immunol. 129:67-75.
11. Wang, Q. P., E. Escudier, F. Roudot-Thoraval, I. A. A. Samad, R. Peynegre, and A. Coste. 1997. Myofibroblast accumulation induced by transforming growth factor-β is involved in the pathogenesis of nasal polyps. Laryngoscope 107:926-931.
12. Smith, S. J., A. M. Piliponsky, M. Hartman, and F. Levi-Schaffer. 2002. Stem cell factor: A possible paradigm between mast cells, eosinophils, and fibroblasts. ACI International 14:52-59.
13. Doucet, C., D. Brouty-Boye, C. Pottin-Clemenceau, C. Jasmin, G. W. Canonica, and B. Azzarone. 1998. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int. Immunol. 10:1421-1433.
14. Moser, R., J. Fehr, and P. L. Bruijnzeel. 1992. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J. Immunol. 149:1432-1438.
15. Schleimer, R. P., S. A. Sterbinsky, J. Kaiser, C. A. Bickel, D. A. Klunk, K. Tomioka, W. Newman, F. W. Luscinskas, M. A. Gimbrone, and B. W. McIntyre. 1992. Interleukin-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J. Immunol. 148:1086-1092.
16. Hoontrakoon, R., J. Kailey, and D. Bratton. 1999. IL-4 and TNF-alpha synergize to enhance eosinophil survival. J. Allergy Clin. Immunol. 103: A239. (Abstr.)
17. Hsieh, C. S., A. B. Heimberger, J. S. Gold, A. O'Garra, and K. M. Murphy. 1992. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA 89:6065-6069.
18. Seder, R. A., W. E. Paul, M. M. Davis, and B. Fazekas de St. Groth. 1992. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091-1098.
19. Jutel, M., W. J. Pichler, D. Skrbic, A. Urwyler, C. Dahinden, and U. R. Muller. 1995. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in allergen-stimulated T cell cultures. J. Immunol. 154:4187-4194.
20. Thivierge, M., J. Stankova, and M. Rola-Pleszczynski. 2001. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J. Immunol. 167:2855-2860.
21. Hsieh, F. H., B. K. Lam, J. F. Penrose, K. F. Austen, and J. A. Boyce. 2001. T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C4 synthase expression by interleukin 4. J. Exp. Med. 193:123-133.
22. Sousa, A. R., A. Parikh, G. Scadding, C. J. Corrigan, and T. H. Lee. 2002. Leukotriene-receptor expression on nasal mucosal inflammatory cells in asprin-sensitive rhinosinusitis. N. Engl. J. Med. 347:1493-1499.
23. Chibana, K., Y. Ishii, T. Asakura, and T. Fukuda. 2003. Up-regulation of cysteinyl leukotriene 1 receptor by IL-13 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin. J. Immunol. 170:4290-4295.
24. Fukushima, N., and J. Chun. 2001. The LPA receptors. Prostaglandins Other Lipid Mediat. 64:21-32.
25. Arm, J. P., S. O'Hickey, B. W. Spur, and T. H. Lee. 1989. Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma. Am. Rev. Respir. Dis. 140:148-153.
26. ten Brinke, A., D. C. Grootendorst, J. T. Schmidt, F. T. de Bruine, M. A. van Buchem, P. J. Sterk, K. F. Rabe, and E. H. Bel. 2002. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J. Allergy Clin. Immunol. 109:621-626.
27. Mellor, E. A., A. Maekawa, K. F. Austen, and J. A. Boyce. 2001. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc. Natl. Acad. Sci. USA 98:7964-7969.
28. Silvestri, M., F. Sabatini, L. Scarso, A. Cordone, G. Dasic, and G. A. Rossi. 2002. Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling. Int. Arch. Allergy Immunol. 128:51-58.
29. Fenton, M. J., J. A. Buras, and R. P. Donnelly. 1992. IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. J. Immunol. 149:1283-1288.
30. Borish, L., and J. W. Steinke. 2003. Cytokines and chemokines. J. Allergy Clin. Immunol. 111:S460-S475.
31. Serhan, C. N., J. Z. Haeggstrom, and C. C. Leslie. 1996. Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J. 10:1147-1158.
32. Roebuck, K. A. 1999. Regulation of interleukin-8 gene expression. J. Interferon Cytokine Res. 19:429-438.
33. Letterio, J. J., and A. B. Roberts. 1998. Regulation of immune repsonses by TGF-β. Annu. Rev. Immunol. 16:137-161.
34. Gleizes, P. E., J. S. Munger, I. Nunes, J. G. Harpel, R. Mazzieri, I. Noguera, and D. B. Rifkin. 1997. TGF-beta latency: biological significance and mechanisms of activation. Stem Cells 15:190-197.
35. Hirschberg, A., A. Jokuti, Z. Darvas, K. Almay, G. Repassy, and A. Falus. 2003. The pathogenesis of nasal polyposis by immunoglobulin E and interluekin-5 is completed by transforming growth factor-β1. Laryngoscope 113:120-124.
36. Eisma, R. J., J. S. Allen, D. Lafreniere, G. Leonard, and D. L. Kreutzer. 1997. Eosinophil expression of transforming growth factor-beta and its receptors in nasal polyposis: role of the cytokines in this disease process. Am. J. Otolaryngol. 18:405-411.
37. Panettieri, R. A., E. M. L. Tan, V. Ciocca, M. A. Luttmann, T. B. Leonard, and D. W. P. Hay. 1998. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am. J. Respir. Cell Mol. Biol. 19:453-461.
38. Medina, L., J. Perez-Ramos, R. Ramirez, M. Selman, and A. Pardo. 1994. Leukotriene C4 upregulates collagenase expression and synthesis in human lung fibroblasts. Biochim. Biophvs. Acta 1224:168-174.
39. Henderson, W. R., L. O. Tang, S. J. Chu, S. M. Tsao, G. K. Chiang, F. Jones, M. Jonas, C. Pae, H. Wang, and E. Y. Chi. 2002. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am. J. Respir. Crit. Care Med. 165:108-116.
40. Wilborn, J., M. Bailie, M. Coffey, M. Burdick, R. Strieter, and M. Peters-Golden. 1996. Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J. Clin. Invest. 97:1827-1836.
41. Kowal-Bielecka, O., O. Distler, K. Kowal, Z. Siergiejko, J. Chwiecko, A. Sulik, R. E. Gay, A. B. Lukaszyk, S. Gay, and S. Sierakowski. 2003. Elevated levels of leukotriene B4 and leukotriene E4 in bronchoalveolar lavage fluid from patients with scleroderma lung disease. Arthritis Rheum. 48:1639-1646.
42. Titos, E., J. Claria, R. Bataller, M. Bosch-Marce, P. Gines, W. Jimenez, V. Arroyo, F. Rivera, and J. Rodes. 2000. Hepatocyte-derived cysteinyl leukotrienes modulate vascular tone in experimental cirrhosis. Gastroenterology 119:794-805.
43. Kowal-Bielecka, O., O. Distler, M. Neidhart, P. Kunzler, J. Rethage, M. Nawrath, A. Carossino, T. Pap, U. Muller-Lander, B. A. Michel, S. Sierakowski, M. Matucci-Cerinic, R. E. Gay, and S. Gay. 2001. Evidence of 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis: a newly identified pathway to skin inflammation in systemic sclerosis. Arthritis Rheum. 44:1865-1875.
44. Davies, D. E., J. Wicks, R. M. Powell, S. M. Puddicombe, and S. T. Holgate. 2003. Airway remodeling in asthma: new insights. J. Allergy Clin. Immunol. 111:215-225.